Symbols / ALTO $4.54 -2.89% Alto Ingredients, Inc.
ALTO Chart
About
Alto Ingredients, Inc. produces, distributes, and markets specialty alcohols, renewable fuel, and essential ingredients in the United States. The company operates in three segments: Marketing and Distribution, Pekin Campus Production, and Western Production. It offers specialty alcohols used in mouthwash, cosmetics, pharmaceuticals, hand sanitizers, disinfectants, and cleaners for health, home, and beauty markets; grain neutral spirits used in alcoholic beverages and vinegar, as well as corn germ used in corn oils in the food and beverage markets; alcohols and other products for paint applications and fertilizers in the industrial and agriculture markets; and essential ingredients, including dried yeast, corn protein meal, corn protein feed, corn germ, distillers grains, and liquid feed for commercial animal feed and pet food applications, as well as yeast and gas liquid CO2 for human consumption. The company also provides fuel-grade ethanol used as transportation fuel additives and distillers corn oil used as a renewable diesel and biodiesel feedstock, as well as fuel-grade ethanol produced by third parties. In addition, it offers transportation, storage, and delivery services through third-party service providers. Further, the company operates alcohol production facilities. It sells ethanol to integrated oil companies and gasoline marketers; essential ingredient feed products to dairies and feedlots; and corn oil to poultry, renewable diesel, and biodiesel customers. The company was formerly known as Pacific Ethanol, Inc. and changed its name to Alto Ingredients, Inc. in January 2021. Alto Ingredients, Inc. was founded in 2003 and is headquartered in Pekin, Illinois.
Fundamentals
Scroll to Statements| Sector | Basic Materials | Industry | Specialty Chemicals | Market Cap | 350.75M |
| Enterprise Value | 435.14M | Income | 12.07M | Sales | 917.93M |
| Book/sh | 3.17 | Cash/sh | 0.30 | Dividend Yield | — |
| Payout | 0.00% | Employees | 390 | IPO | — |
| P/E | 28.34 | Forward P/E | 12.96 | PEG | — |
| P/S | 0.38 | P/B | 1.43 | P/C | — |
| EV/EBITDA | 13.22 | EV/Sales | 0.47 | Quick Ratio | 1.46 |
| Current Ratio | 2.64 | Debt/Eq | 39.80 | LT Debt/Eq | — |
| EPS (ttm) | 0.16 | EPS next Y | 0.35 | EPS Growth | — |
| Revenue Growth | -1.90% | Earnings | 2026-05-06 | ROA | 1.22% |
| ROE | 5.67% | ROIC | — | Gross Margin | 3.80% |
| Oper. Margin | 3.57% | Profit Margin | 1.45% | Shs Outstand | 77.29M |
| Shs Float | 68.98M | Short Float | 2.05% | Short Ratio | 0.62 |
| Short Interest | — | 52W High | 5.06 | 52W Low | 0.76 |
| Beta | 0.06 | Avg Volume | 1.59M | Volume | 1.08M |
| Target Price | $5.00 | Recom | None | Prev Close | $4.67 |
| Price | $4.54 | Change | -2.89% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-03-06 | reit | HC Wainwright & Co. | Buy → Buy | $6 |
| 2024-08-07 | reit | HC Wainwright & Co. | Buy → Buy | $6 |
| 2024-05-07 | reit | HC Wainwright & Co. | Buy → Buy | $6 |
| 2024-03-12 | main | Craig-Hallum | Buy → Buy | $4 |
| 2024-03-12 | reit | HC Wainwright & Co. | Buy → Buy | $6 |
| 2023-11-06 | main | HC Wainwright & Co. | Buy → Buy | $6 |
| 2023-08-08 | reit | HC Wainwright & Co. | Buy → Buy | $7 |
| 2023-02-07 | reit | HC Wainwright & Co. | — → Buy | $10 |
| 2021-01-29 | init | Guggenheim | — → Buy | $11 |
- Alto Ingredients (ALTO) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance Mon, 06 Apr 2026 16
- PANW Stock Quote Price and Forecast - CNN Sat, 04 Apr 2026 08
- Alto Ingredients Trades at a Premium Valuation: How to Play the Stock - Zacks Investment Research Wed, 01 Apr 2026 16
- Top 1% Biotech Crashes On A Shock For Its Top Drug - Investor's Business Daily hu, 02 Apr 2026 20
- From $60.3M loss to profit: how Alto Ingredients turned 2025 around - Stock Titan Wed, 04 Mar 2026 08
- Alto Ingredients: What's The Next Move After A Long-Awaited Comeback? (NASDAQ:ALTO) - Seeking Alpha Mon, 09 Mar 2026 07
- JonesTrading Issues Pessimistic Forecast for Alto Neuroscience (NYSE:ANRO) Stock Price - MarketBeat hu, 02 Apr 2026 15
- Alto Neuroscience stock falls after trial misses primary endpoint - Investing.com Wed, 01 Apr 2026 20
- Why Palo Alto Networks Stock Dropped Today - The Motley Fool Fri, 27 Mar 2026 07
- Why Alto Ingredients Stock Is Surging 50% Today - Finviz hu, 05 Mar 2026 08
- ALTO INGREDIENTS ($ALTO) Releases Q4 2025 Earnings, Stock Rises - Quiver Quantitative Wed, 04 Mar 2026 08
- Is Marketing and Distribution Segment Boosting ALTO's Growth Story? - The Globe and Mail hu, 02 Apr 2026 17
- After a Phase 2 miss, Alto shifts focus to depression drug ALTO-207 - Stock Titan Wed, 01 Apr 2026 20
- H.C. Wainwright reiterates Alto Neuroscience stock rating at buy By Investing.com - Investing.com UK Mon, 06 Apr 2026 11
- Is Alto Ingredients (ALTO) Stock Outpacing Its Consumer Discretionary Peers This Year? - Yahoo Finance Wed, 31 Dec 2025 08
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
917.93
-4.90%
|
965.26
-21.07%
|
1,222.94
-8.44%
|
1,335.62
|
| Operating Revenue |
|
917.93
-4.90%
|
965.26
-21.07%
|
1,222.94
-8.44%
|
1,335.62
|
| Cost Of Revenue |
|
883.01
-7.59%
|
955.54
-20.85%
|
1,207.29
-11.44%
|
1,363.17
|
| Reconciled Cost Of Revenue |
|
883.01
-7.59%
|
955.54
-20.85%
|
1,207.29
-11.44%
|
1,363.17
|
| Gross Profit |
|
34.91
+259.11%
|
9.72
-37.89%
|
15.65
+156.82%
|
-27.55
|
| Operating Expense |
|
19.71
-33.72%
|
29.74
+9.92%
|
27.05
+398.47%
|
5.43
|
| Selling General And Administration |
|
27.21
-8.50%
|
29.74
-0.43%
|
29.86
+6.36%
|
28.08
|
| Other Operating Expenses |
|
—
|
—
|
-2.81
+87.59%
|
-22.65
|
| Total Expenses |
|
902.72
-8.38%
|
985.27
-20.18%
|
1,234.34
-9.81%
|
1,368.60
|
| Operating Income |
|
15.21
+175.97%
|
-20.01
-75.58%
|
-11.40
+65.43%
|
-32.98
|
| Total Operating Income As Reported |
|
7.36
+114.25%
|
-51.67
-116.68%
|
-23.85
+61.13%
|
-61.36
|
| EBITDA |
|
48.70
+281.99%
|
-26.76
-1130.38%
|
2.60
+120.37%
|
-12.75
|
| Normalized EBITDA |
|
42.35
+763.99%
|
4.90
-59.93%
|
12.23
+274.27%
|
-7.02
|
| Reconciled Depreciation |
|
25.22
+3.31%
|
24.41
+5.75%
|
23.08
-8.03%
|
25.09
|
| EBIT |
|
23.48
+145.89%
|
-51.17
-149.80%
|
-20.48
+45.88%
|
-37.84
|
| Total Unusual Items |
|
6.34
+120.04%
|
-31.66
-228.54%
|
-9.64
-68.18%
|
-5.73
|
| Total Unusual Items Excluding Goodwill |
|
6.34
+120.04%
|
-31.66
-228.54%
|
-9.64
-68.18%
|
-5.73
|
| Special Income Charges |
|
6.34
+120.04%
|
-31.66
-228.54%
|
-9.64
-68.18%
|
-5.73
|
| Other Special Charges |
|
-6.69
|
—
|
—
|
—
|
| Impairment Of Capital Assets |
|
—
|
—
|
—
|
—
|
| Restructuring And Mergern Acquisition |
|
-0.46
-105.97%
|
7.70
+175.04%
|
2.80
-20.00%
|
3.50
|
| Write Off |
|
0.80
-96.76%
|
24.79
+278.82%
|
6.54
|
0.00
|
| Net Income |
|
13.34
+122.61%
|
-58.98
-110.62%
|
-28.00
+32.68%
|
-41.60
|
| Pretax Income |
|
12.72
+121.62%
|
-58.81
-110.73%
|
-27.91
+29.65%
|
-39.67
|
| Net Non Operating Interest Income Expense |
|
-10.77
-40.83%
|
-7.64
-2.95%
|
-7.42
-306.40%
|
-1.83
|
| Interest Expense Non Operating |
|
10.77
+40.83%
|
7.64
+2.95%
|
7.42
+306.40%
|
1.83
|
| Net Interest Income |
|
-10.77
-40.83%
|
-7.64
-2.95%
|
-7.42
-306.40%
|
-1.83
|
| Interest Expense |
|
10.77
+40.83%
|
7.64
+2.95%
|
7.42
+306.40%
|
1.83
|
| Other Income Expense |
|
8.28
+126.57%
|
-31.15
-242.94%
|
-9.08
-86.61%
|
-4.87
|
| Other Non Operating Income Expenses |
|
1.93
+280.31%
|
0.51
-8.14%
|
0.55
-35.85%
|
0.86
|
| Tax Provision |
|
-0.62
-458.96%
|
0.17
+78.35%
|
0.10
-94.96%
|
1.93
|
| Tax Rate For Calcs |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
|
| Tax Effect Of Unusual Items |
|
1.33
+120.04%
|
-6.65
-228.54%
|
-2.02
-68.18%
|
-1.20
|
| Net Income Including Noncontrolling Interests |
|
13.34
+122.61%
|
-58.98
-110.62%
|
-28.00
+32.68%
|
-41.60
|
| Net Income From Continuing Operation Net Minority Interest |
|
13.34
+122.61%
|
-58.98
-110.62%
|
-28.00
+32.68%
|
-41.60
|
| Net Income From Continuing And Discontinued Operation |
|
13.34
+122.61%
|
-58.98
-110.62%
|
-28.00
+32.68%
|
-41.60
|
| Net Income Continuous Operations |
|
13.34
+122.61%
|
-58.98
-110.62%
|
-28.00
+32.68%
|
-41.60
|
| Minority Interests |
|
—
|
—
|
—
|
0.00
|
| Normalized Income |
|
8.33
+124.51%
|
-33.97
-66.60%
|
-20.39
+44.99%
|
-37.07
|
| Net Income Common Stockholders |
|
12.07
+120.04%
|
-60.25
-105.85%
|
-29.27
+31.71%
|
-42.86
|
| Otherunder Preferred Stock Dividend |
|
—
|
—
|
0.00
|
0.00
|
| Diluted EPS |
|
0.16
+119.51%
|
-0.82
-105.00%
|
-0.40
+33.33%
|
-0.60
|
| Basic EPS |
|
0.16
+119.51%
|
-0.82
-105.00%
|
-0.40
+33.33%
|
-0.60
|
| Basic Average Shares |
|
74.51
+1.39%
|
73.48
+0.19%
|
73.34
+1.94%
|
71.94
|
| Diluted Average Shares |
|
75.66
+2.97%
|
73.48
+0.19%
|
73.34
+1.94%
|
71.94
|
| Diluted NI Availto Com Stockholders |
|
12.07
+120.04%
|
-60.25
-105.85%
|
-29.27
+31.71%
|
-42.86
|
| Gain On Sale Of PPE |
|
0.00
-100.00%
|
0.83
+383.28%
|
-0.29
+86.86%
|
-2.23
|
| Other Taxes |
|
-7.50
|
0.00
|
0.00
|
—
|
| Preferred Stock Dividends |
|
1.26
-0.32%
|
1.27
+0.32%
|
1.26
+0.00%
|
1.26
|
| Line Item | Trend | 2023-12-31 |
|---|---|---|
| Total Assets |
|
454.24
|
| Current Assets |
|
168.77
|
| Cash Cash Equivalents And Short Term Investments |
|
30.01
|
| Cash And Cash Equivalents |
|
30.01
|
| Receivables |
|
58.73
|
| Accounts Receivable |
|
58.73
|
| Gross Accounts Receivable |
|
58.81
|
| Allowance For Doubtful Accounts Receivable |
|
-0.09
|
| Taxes Receivable |
|
—
|
| Inventory |
|
52.61
|
| Raw Materials |
|
10.31
|
| Work In Process |
|
5.06
|
| Finished Goods |
|
35.77
|
| Restricted Cash |
|
15.47
|
| Assets Held For Sale Current |
|
—
|
| Hedging Assets Current |
|
2.41
|
| Other Current Assets |
|
9.54
|
| Total Non Current Assets |
|
285.47
|
| Net PPE |
|
271.35
|
| Gross PPE |
|
491.52
|
| Accumulated Depreciation |
|
-220.17
|
| Properties |
|
0.00
|
| Land And Improvements |
|
3.69
|
| Machinery Furniture Equipment |
|
414.73
|
| Construction In Progress |
|
50.51
|
| Other Properties |
|
22.60
|
| Goodwill And Other Intangible Assets |
|
8.50
|
| Goodwill |
|
0.00
|
| Other Intangible Assets |
|
8.50
|
| Other Non Current Assets |
|
5.63
|
| Total Liabilities Net Minority Interest |
|
174.68
|
| Current Liabilities |
|
65.29
|
| Payables And Accrued Expenses |
|
40.96
|
| Payables |
|
20.75
|
| Accounts Payable |
|
20.75
|
| Current Accrued Expenses |
|
20.20
|
| Current Debt And Capital Lease Obligation |
|
4.33
|
| Current Debt |
|
—
|
| Other Current Borrowings |
|
—
|
| Current Capital Lease Obligation |
|
4.33
|
| Other Current Liabilities |
|
20.00
|
| Total Non Current Liabilities Net Minority Interest |
|
109.40
|
| Long Term Debt And Capital Lease Obligation |
|
101.13
|
| Long Term Debt |
|
82.10
|
| Long Term Capital Lease Obligation |
|
19.03
|
| Other Non Current Liabilities |
|
8.27
|
| Stockholders Equity |
|
279.56
|
| Common Stock Equity |
|
279.56
|
| Capital Stock |
|
0.08
|
| Common Stock |
|
0.08
|
| Preferred Stock |
|
0.00
|
| Share Issued |
|
75.70
|
| Ordinary Shares Number |
|
75.70
|
| Treasury Shares Number |
|
0.00
|
| Additional Paid In Capital |
|
1,040.91
|
| Retained Earnings |
|
-763.91
|
| Gains Losses Not Affecting Retained Earnings |
|
2.48
|
| Other Equity Adjustments |
|
2.48
|
| Total Equity Gross Minority Interest |
|
279.56
|
| Total Capitalization |
|
361.65
|
| Working Capital |
|
103.48
|
| Invested Capital |
|
361.65
|
| Total Debt |
|
105.46
|
| Net Debt |
|
52.08
|
| Capital Lease Obligations |
|
23.36
|
| Net Tangible Assets |
|
271.06
|
| Tangible Book Value |
|
271.06
|
| Non Current Note Receivables |
|
—
|
| Other Inventories |
|
1.47
|
| Preferred Shares Number |
|
0.93
|
| Preferred Stock Equity |
|
0.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
13.24
+476.17%
|
-3.52
-115.99%
|
22.02
+264.11%
|
6.05
|
| Cash Flow From Continuing Operating Activities |
|
13.24
+476.17%
|
-3.52
-115.99%
|
22.02
+264.11%
|
6.05
|
| Net Income From Continuing Operations |
|
13.34
+122.61%
|
-58.98
-110.62%
|
-28.00
+32.68%
|
-41.60
|
| Depreciation Amortization Depletion |
|
25.22
+3.31%
|
24.41
+5.75%
|
23.08
-8.03%
|
25.09
|
| Depreciation |
|
—
|
—
|
—
|
—
|
| Depreciation And Amortization |
|
25.22
+3.31%
|
24.41
+5.75%
|
23.08
-8.03%
|
25.09
|
| Other Non Cash Items |
|
2.82
-27.11%
|
3.87
-4.44%
|
4.05
-17.60%
|
4.92
|
| Stock Based Compensation |
|
3.02
-30.64%
|
4.36
+11.83%
|
3.90
+16.89%
|
3.33
|
| Asset Impairment Charge |
|
0.86
-96.54%
|
24.74
+254.90%
|
6.97
+3312.44%
|
-0.22
|
| Deferred Tax |
|
-7.50
|
0.00
|
0.00
|
—
|
| Deferred Income Tax |
|
-7.50
|
0.00
|
0.00
|
—
|
| Operating Gains Losses |
|
-8.07
+32.06%
|
-11.88
-242.66%
|
8.32
+148.87%
|
-17.03
|
| Gain Loss On Investment Securities |
|
-8.07
+26.95%
|
-11.04
-237.53%
|
8.03
+141.69%
|
-19.26
|
| Change In Working Capital |
|
-16.44
-265.01%
|
9.96
+168.62%
|
3.71
-88.25%
|
31.55
|
| Change In Receivables |
|
3.31
+489.68%
|
0.56
-94.08%
|
9.50
-60.37%
|
23.97
|
| Changes In Account Receivables |
|
3.31
+489.68%
|
0.56
-94.08%
|
9.50
-60.37%
|
23.97
|
| Change In Inventory |
|
-12.62
-381.33%
|
4.48
-62.05%
|
11.82
+176.34%
|
-15.48
|
| Change In Payables And Accrued Expense |
|
-2.83
-128.43%
|
9.95
+179.27%
|
-12.55
-161.23%
|
20.50
|
| Change In Other Working Capital |
|
-6.59
-10.46%
|
-5.96
-11.25%
|
-5.36
-4.56%
|
-5.13
|
| Change In Other Current Assets |
|
2.28
+144.79%
|
0.93
+200.32%
|
0.31
-95.97%
|
7.69
|
| Change In Other Current Liabilities |
|
—
|
—
|
0.00
|
0.00
|
| Investing Cash Flow |
|
-7.43
+44.85%
|
-13.47
+59.23%
|
-33.03
+12.30%
|
-37.66
|
| Cash Flow From Continuing Investing Activities |
|
-7.43
+44.85%
|
-13.47
+59.23%
|
-33.03
+12.30%
|
-37.66
|
| Net PPE Purchase And Sale |
|
-4.60
+58.46%
|
-11.07
+62.53%
|
-29.53
+21.76%
|
-37.74
|
| Purchase Of PPE |
|
-4.60
+58.46%
|
-11.07
+62.53%
|
-29.53
+21.76%
|
-37.74
|
| Capital Expenditure |
|
-4.60
+58.46%
|
-11.07
+62.53%
|
-29.53
+21.76%
|
-37.74
|
| Net Business Purchase And Sale |
|
-9.52
-239.93%
|
-2.80
+20.00%
|
-3.50
+76.17%
|
-14.69
|
| Purchase Of Business |
|
-9.52
-239.93%
|
-2.80
+20.00%
|
-3.50
+76.17%
|
-14.69
|
| Net Other Investing Changes |
|
6.69
+1572.00%
|
0.40
|
—
|
14.77
|
| Financing Cash Flow |
|
-16.36
-311.92%
|
7.72
+10.87%
|
6.96
-63.39%
|
19.01
|
| Cash Flow From Continuing Financing Activities |
|
-16.36
-311.92%
|
7.72
+10.87%
|
6.96
-63.39%
|
19.01
|
| Net Issuance Payments Of Debt |
|
-15.09
-267.92%
|
8.99
-28.75%
|
12.61
-52.89%
|
26.77
|
| Issuance Of Debt |
|
—
|
0.00
|
0.00
-100.00%
|
59.10
|
| Repayment Of Debt |
|
-5.00
|
0.00
|
0.00
|
0.00
|
| Long Term Debt Issuance |
|
—
|
0.00
|
0.00
-100.00%
|
59.10
|
| Long Term Debt Payments |
|
-5.00
|
0.00
|
0.00
|
0.00
|
| Net Long Term Debt Issuance |
|
-5.00
|
0.00
|
0.00
-100.00%
|
59.10
|
| Short Term Debt Issuance |
|
—
|
—
|
—
|
—
|
| Net Short Term Debt Issuance |
|
-10.09
-212.28%
|
8.99
-28.75%
|
12.61
+139.02%
|
-32.33
|
| Net Common Stock Issuance |
|
0.00
|
0.00
+100.00%
|
-3.67
-177.28%
|
-1.32
|
| Common Stock Payments |
|
0.00
|
0.00
+100.00%
|
-3.67
-177.28%
|
-1.32
|
| Cash Dividends Paid |
|
-1.26
+0.32%
|
-1.27
-0.32%
|
-1.26
+0.00%
|
-1.26
|
| Repurchase Of Capital Stock |
|
0.00
|
0.00
+100.00%
|
-3.67
-177.28%
|
-1.32
|
| Proceeds From Stock Option Exercised |
|
—
|
—
|
—
|
0.00
|
| Net Other Financing Charges |
|
—
|
—
|
-0.71
+86.19%
|
-5.17
|
| Changes In Cash |
|
-10.54
-13.69%
|
-9.27
-129.15%
|
-4.04
+67.90%
|
-12.60
|
| Beginning Cash Position |
|
36.21
-20.38%
|
45.48
-8.17%
|
49.52
-20.28%
|
62.12
|
| End Cash Position |
|
25.67
-29.10%
|
36.21
-20.38%
|
45.48
-8.17%
|
49.52
|
| Free Cash Flow |
|
8.65
+159.29%
|
-14.59
-94.34%
|
-7.51
+76.32%
|
-31.70
|
| Interest Paid Supplemental Data |
|
9.05
-16.52%
|
10.84
+4.42%
|
10.38
+254.41%
|
2.93
|
| Income Tax Paid Supplemental Data |
|
0.01
|
—
|
0.32
-85.68%
|
2.26
|
| Common Stock Issuance |
|
—
|
—
|
0.00
|
0.00
|
| Issuance Of Capital Stock |
|
—
|
—
|
0.00
|
0.00
|
| Preferred Stock Dividend Paid |
|
-1.26
+0.32%
|
-1.27
-0.32%
|
-1.26
+0.00%
|
-1.26
|
| Sale Of Business |
|
—
|
—
|
0.00
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-04-03 View
- 42026-04-03 View
- 42026-04-03 View
- 42026-04-03 View
- 42026-04-03 View
- 42026-03-19 View
- 42026-03-19 View
- 42026-03-19 View
- 42026-03-19 View
- 42026-03-19 View
- 10-K2026-03-13 View
- 8-K2026-03-04 View
- 8-K2025-11-26 View
- 10-Q2025-11-07 View
- 8-K2025-11-05 View
- 42025-08-14 View
- 10-Q2025-08-08 View
- 8-K2025-08-06 View
- 42025-07-11 View
- 42025-07-11 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|